Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

986 ARTÍCULOS , VIENDO DEL 61 AL 75

Silent Echoes: A Case Report of Wernicke Encephalopathy's Unheard Voice

Gafoor S, Robertson R.

Cureus. 2024 Jan 12;16(1):e52151. doi: 10.7759/cureus.52151. eCollection 2024 Jan.

Nocturnal vestibular stimulation using a rocking bed improves a severe sleep disorder in a patient with mitochondrial disease

Breuss A, Strasser M, Nuoffer JM, Klein A, Perret-Hoigné E, Felder C, Stauffer R, Wolf P, Riener R, Gautschi M.

J Sleep Res. 2024 Dec;33(6):e14153. doi: 10.1111/jsr.14153. Epub 2024 Mar 18.

Intrathecal topotecan with systemic checkpoint inhibitor therapy for gastroesophageal cancer with leptomeningeal involvement: two case reports and review of the literature

Pabon CM, Yeboa DN, O'Brien BJ, Majd NK, Wang C, Blum Murphy MA.

J Gastrointest Oncol. 2024 Jun 30;15(3):1331-1340. doi: 10.21037/jgo-24-70. Epub 2024 Jun 20.

Hereditary spastic paraplegia and extensive leukoencephalopathy: a case report of a unique phenotype associated with a GJB1/Cx32 p.Pro174Ser variant

Nakamura H, Doi H, Miyaji Y, Wada T, Takahashi E, Tada M, Fukuda H, Fujita A, Higashiyama Y, Nagao Y, Kimura K, Hayashi M, Hoshino K, Matsumoto N, Tanaka F.

BMC Neurol. 2024 Sep 4;24(1):310. doi: 10.1186/s12883-024-03823-9.

Hereditary Transthyretin Amyloidosis

Sekijima Y, Nakamura K.

2001 Nov 5 [updated 2024 May 30]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(®) [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026.

Upper limb intention tremor assessment: opportunities and challenges in wearable technology

Paredes-Acuna N, Utpadel-Fischler D, Ding K, Thakor NV, Cheng G.

J Neuroeng Rehabil. 2024 Jan 13;21(1):8. doi: 10.1186/s12984-023-01302-9.

Targeting ATR in patients with cancer

Ngoi NYL, Pilié PG, McGrail DJ, Zimmermann M, Schlacher K, Yap TA.

Nat Rev Clin Oncol. 2024 Apr;21(4):278-293. doi: 10.1038/s41571-024-00863-5. Epub 2024 Feb 20.

Familial cerebral amyloid disorders with prominent white matter involvement

Banerjee G, Schott JM, Ryan NS.

Handb Clin Neurol. 2024;204:289-315. doi: 10.1016/B978-0-323-99209-1.00010-7.

Hypophysitis and central nervous system involvement in association with Sjögren's syndrome along with hypoparathyroidism: a case report

Yum J, Lee SW, Rhee Y, Heo K.

BMC Neurol. 2024 Sep 12;24(1):339. doi: 10.1186/s12883-024-03845-3.

An Update on Parkinson's Disease and its Neurodegenerative Counterparts

Adam H, Gopinath SCB, Arshad MKM, Adam T, Subramaniam S, Hashim U.

Curr Med Chem. 2024;31(19):2770-2787. doi: 10.2174/0929867330666230403085733.

[What's behind cerebellar dizziness? - News on diagnosis and therapy]

Feil K, Rattay TW, Adeyemi AK, Goldschagg N, Strupp ML.

Laryngorhinootologie. 2024 May;103(5):337-343. doi: 10.1055/a-2192-7278. Epub 2023 Nov 21.

Multiple system atrophy: an update and emerging directions of biomarkers and clinical trials

Liu M, Wang Z, Shang H.

J Neurol. 2024 May;271(5):2324-2344. doi: 10.1007/s00415-024-12269-5. Epub 2024 Mar 14.

Triple-Negative Breast Cancer and Emerging Therapeutic Strategies: ATR and CHK1/2 as Promising Targets

Sofianidi A, Dumbrava EE, Syrigos KN, Nasrazadani A.

Cancers (Basel). 2024 Mar 13;16(6):1139. doi: 10.3390/cancers16061139.

A Review of the Repair of DNA Double Strand Breaks in the Development of Oral Cancer

Prime SS, Darski P, Hunter KD, Cirillo N, Parkinson EK.

Int J Mol Sci. 2024 Apr 7;25(7):4092. doi: 10.3390/ijms25074092.

Predicting age of onset and progression of disease in late-onset genetic neurodegenerative diseases: An ethics review and research agenda

Rensink M, Bolt I, Schermer M.

Eur J Hum Genet. 2024 Nov;32(11):1361-1370. doi: 10.1038/s41431-024-01688-7. Epub 2024 Sep 24.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias